Upgrade to SI Premium - Free Trial

Unusual 11 Mid-Day Movers 8/30: (RIGL) (KPTI) (RBA) Higher; (ANF) (CBK) (GIII) Lower

August 30, 2016 12:56 PM
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) 50.8% HIGHER; announced that fostamatinib, its oral spleen tyrosine kinase (SYK) inhibitor, met the primary ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles